Sixteen patients with either recurrent symptomatic supraventricular tachycardia (SVT)(ten) or
ventricular tachycardia (VT)(six) unresponsive to drug treatment underwent insertion of …

Abstract Over a 14-year period, 53 patients received implanted pacemakers to assist in the
control of recurrent tachycardias. Indications were: prevention of tachycardia in 2 patients …

Recurrent, drug-refractory sustained tachycardias present a difficult management problem.
After invasive electrophysiologic study and extensive antiarrhythmic drug testing, a …

A pacemaker was used to control drug‐resistant reentrant Supraventricular tachycardia
(SVT) in 40 patients. An antitachycardia pacemaker was impJanted in 37 for SVT; in one for …

This report describes the multicenter experience of the Tachylog antitachycardia pacemaker
(Siemens-Elema) in the treatment of drug-refractory, recurrent supraventricular arrhythmias …

This report describes the Jong‐term follow‐up of two patients who received implantable
automatic burst tachycardia‐terminating ventricular pacemakers for the treatment of drug …

Permanent pacemakers capable of triggered ventricular stimulation were implanted in 28
patients with a history of sustained ventricular tachycardia or fibrillation. Noninvasive …

A new antitachycardia pacemaker system was used in a 58 year old woman to terminate two
different types of supravehtricular tachycardia by a single automatic pacing mode. During …

Patient reports are presented to indicate the application of standard implanted
programmable pacemakers with endocardial electrodes for long‐term overdrive …

Chronic recurrent ventricular tachycardia (VT) can be terminated reproducibly by
programmed endocardial right ventricular stimulation. However, antitachycardia pacing is …